Youll get a unique vinyl record
TRIUMPH-4 Phase III: 28.7% weight loss at 68 weeks highest ever recorded.Retatrutide vs Semaglutide vs TirzepatideRetatrutide: 28.7% weight loss (68 wk) Triple agonist (GLP-1+GIP+GCGR)Tirzepatide (Mounjaro/Zepbound): 22.5% (72 wk) Dual agonist (GLP-1+GIP)Semaglutide (Wegovy/Ozempic): 15-17% (68 wk) GLP-1 onlyKey Clinical Results (April 2026)TRIUMPH-4 Phase III (Dec 2025): 28.7% body weight reduction, 71.2 lbs lost at 12mg doseTRANSCEND-T2D-1 (Mar 2026): 2.0% HbA1c reduction, 16.8% weight loss in type 2 diabetesPhase II (NEJM 2023): 24.2% weight loss at 48 weeks, no plateau observedFDA NDA submission: Q4 2026-Q1 2027Research-Grade RetatrutideBioInfinity Lab GLP3-R: 99%+ purity, third-party COA verified, GMP compliant
Stopping Safely Some people stop taking medications such as Lexapro and Prozac because of weight gain and other side effects
Suitability depends on factors such as BMI, medical history, existing health conditions and current medications rather than Hashimotos disease alone
Choosing the Right Peptide for You Factors to consider when choosing between Ipamorelin and Sermorelin When you consider a treatment between Ipamorelin and Sermorelin , factors to consider depends on the patient's treatment goals, tolerance to side effects, and how often you want to have the injections
A robust immune system supports your overall health and helps you stay well